Lisa Sunin
Showing 1–2 of 2 transcripts.
- Milken Institute1h 0m
Regulating Medical Innovation in the Digital Age
Lisa Suennen, William Carson, Aneesh Chopra, Sohini Chowdhury, Lucia Savage, Jeffrey Shuren, Lisa Sunin, Jeff Sheeran, Bill Carson
A panel of industry leaders and FDA officials analyzed the surge in digital healthcare investment, which has exceeded $40 billion, while addressing regulatory hurdles that slow the development of Software as a Medical Device. Key discussions highlighted the FDA's "Pre-Cert" pilot program and the critical need for interoperability standards like FHIR to reduce data costs and overcome fragmentation in telemedicine and direct-to-consumer markets. Despite breakthroughs such as the first digital medicine approval, experts emphasized that legacy frameworks struggle to accommodate rapid software iteration, opaque deep learning algorithms, and complex data privacy requirements across 57 state and federal jurisdictions.
- Milken Institute1h 1m
Silver Strategies: Capitalizing on the Longevity Economy
Dr. Joe Coughlin, Gretchen Addy, Paul Irving, Lisa Sunin, Jenny
A recent analysis highlights the Longevity Economy as a $7.1 trillion global market driven by the spending and innovation of the 50+ demographic, yet current venture capital and product design often fail to address this group's $100 billion annual anti-aging spend due to ageist biases and poor human-centered design. Experts like Lisa Sunin, Gretchen Addy, and Paul Irving argue that overcoming these barriers requires shifting from an illness-based narrative to lifestyle-focused strategies, specifically targeting high-opportunity sectors such as dementia care, home-based aging services, and preventive digital health. By reimagining products for active "third-age" living and fostering intergenerational workforce integration, stakeholders can unlock significant growth in a sector where investors like Peter Thiel and Larry Ellison are increasingly directing capital.